Receptor to slow breast cancer metastasis identified

By therapeutically targeting the receptor for advanced glycation end-products (RAGE) in breast cancer cells, researchers decreased tumor growth, reduced tumor angiogenesis and recruitment of inflammatory cells, and dramatically decreased metastasis to the lung and the liver.